Pat O’Sullivan
Chief Operating Officer at AMICUS THERAPEUTICS, INC.
Profile
Pat O’Sullivan currently works at Amicus Therapeutics, Inc., as Chief Technical Operations Officer from 2022.
Mr. O’Sullivan also formerly worked at Genzyme Therapeutics Ltd., as Vice President-Global Supply Chain from 2001 to 2022.
Mr. O’Sullivan received his Masters Business Admin degree from The Open University and undergraduate degree from Munster Technological University.
Pat O’Sullivan active positions
| Companies | Position | Start |
|---|---|---|
| AMICUS THERAPEUTICS, INC. | Chief Operating Officer | 30/06/2022 |
Former positions of Pat O’Sullivan
| Companies | Position | End |
|---|---|---|
Genzyme Therapeutics Ltd.
 Genzyme Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Genzyme Therapeutics Ltd. develops transformative therapies for patients affected by rare and debilitating diseases. Its treatment areas include thyroid cancer, sclerosis, Fabry disease and Pompe. The company was founded on November 5, 2001 and is headquartered in Oxford, the United Kingdom. | Corporate Officer/Principal | 31/07/2022 |
Training of Pat O’Sullivan
| The Open University | Masters Business Admin |
| Munster Technological University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| AMICUS THERAPEUTICS, INC. | Health Technology |
| Private companies | 1 |
|---|---|
Genzyme Therapeutics Ltd.
Genzyme Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Genzyme Therapeutics Ltd. develops transformative therapies for patients affected by rare and debilitating diseases. Its treatment areas include thyroid cancer, sclerosis, Fabry disease and Pompe. The company was founded on November 5, 2001 and is headquartered in Oxford, the United Kingdom. | Health Technology |
- Stock Market
- Insiders
- Pat O’Sullivan
